MGRX Mangoceuticals, Inc.

Fundamentals / CIK 0001938046 / USD

Mangoceuticals, Inc. reported $300K in revenue and a net loss of $11.04M for the trailing twelve months ended September 30, 2026 (down 17.5% year over year), with a 52.9% gross margin and a -2887.5% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MGRX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

4 fiscal years (2022 to 2025), reported in USD.

$2.90M$1.45M$0-$19.36MFY 2022 Revenue: $8.9KFY 2022 Net Income: -$2.00M2022FY 2023 Revenue: $731KFY 2023 Net Income: -$9.21M2023FY 2024 Revenue: $616KFY 2024 Net Income: -$8.71M2024FY 2025 Revenue: $456KFY 2025 Net Income: -$20.64M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31
Revenue $456K $616K $731K $8.9K
Cost of Revenue $54K $93K $155K $4.1K
Gross Profit $250K $380K $432K $4.8K
Total Operating Expenses $18.28M $8.35M $9.65M $2.00M
Operating Income -$18.03M -$7.97M -$9.22M -$1.99M
EBITDA -$16.91M -$7.96M -$9.19M -$1.99M
Interest Expense $104K $14K -$6.5K $6.5K
Income Before Tax -$20.64M -$8.71M -$9.21M -$2.00M
Net Income -$20.64M -$8.71M -$9.21M -$2.00M
Basic EPS -$2.17 -$4.80 -$8.58 -$2.85
Diluted EPS -$2.17 -$4.80 -$8.58 -$2.85
Basic Shares Outstanding 10.1M 2.0M 1.1M 719.9K
Diluted Shares Outstanding 10.1M 2.0M 1.1M 719.9K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $70K $69K $68K $94K $84K $168K $109K $105K
Cost of Revenue $8.8K $10K $8.2K $8.5K $2.4K $19K $25K $21K
Gross Profit $38K $44K $29K $47K $51K $90K $62K $80K
Total Operating Expenses $3.35M $1.08M $3.16M $1.25M $7.31M $5.36M $4.64M $1.76M
Operating Income -$3.31M -$1.03M -$3.13M -$1.21M -$7.26M -$5.27M -$4.58M -$1.68M
EBITDA -$3.03M -$753K -$2.85M -$924K -$7.26M -$5.27M -$4.58M -$1.68M
Interest Expense $1.1K -- -- $20K $76K $22K -$14K --
Income Before Tax -$3.55M -$1.31M -$3.40M -$2.77M -$7.62M -$5.42M -$4.84M -$1.95M
Net Income -$3.55M -$1.31M -$3.40M -$2.77M -$7.62M -$5.42M -$4.84M -$1.95M
Basic EPS -$0.19 -$0.09 -$0.22 -- -$0.69 -$0.57 -$1.12 --
Diluted EPS -$0.19 -$0.09 -$0.22 -- -$0.69 -$0.57 -$1.12 --
Basic Shares Outstanding 20.4M 17.1M 16.5M -- 11.5M 10.0M 4.6M --
Diluted Shares Outstanding 20.4M 17.1M 16.5M -- 11.5M 10.0M 4.6M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $1.49M $59K $739K $683K
Cash & Short-Term Investments $1.49M $59K $739K $683K
Inventory -- -- $19K --
Total Current Assets $1.55M $76K $835K $695K
Property, Plant & Equipment, Net $1.8K $2.8K $96K $117K
Intangible Assets $14.23M $15.23M -- --
Total Non-Current Assets $14.54M $15.29M $215K $309K
Total Assets $16.09M $15.37M $1.05M $1.00M
Other Current Liabilities -- $373K -- --
Total Current Liabilities $891K $1.43M $211K $261K
Total Non-Current Liabilities $0 $0 $65K $129K
Total Liabilities $891K $1.43M $276K $389K
Total Debt (incl. Leases) $308K $65K $129K $185K
Common Stock $1.6K $325 $148 $1.3K
Retained Earnings -$40.65M -$20.00M -$11.23M -$2.02M
Accumulated Other Comp. Income -$2.8K -$9.8K -- --
Total Stockholders' Equity $15.20M $13.95M $775K $614K
Total Equity $15.20M $13.95M $775K $614K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $659K $229K $175K $1.49M $481K $101K $76K $59K
Cash & Short-Term Investments $659K $229K $175K $1.49M $481K $101K $76K $59K
Total Current Assets $1.49M $246K $212K $1.55M $598K $118K $177K $76K
Property, Plant & Equipment, Net $1.0K $1.3K $1.5K $1.8K $2.0K $2.3K $2.6K $2.8K
Intangible Assets $13.35M $13.65M $13.94M $14.23M $15.92M $20.69M $21.53M $15.23M
Total Non-Current Assets $13.62M $13.93M $14.24M $14.54M $15.93M $20.72M $21.58M $15.29M
Total Assets $15.11M $14.17M $14.45M $16.09M $16.53M $20.84M $21.75M $15.37M
Other Current Liabilities -- -- -- -- -- -- -- $373K
Total Current Liabilities $1.16M $1.40M $738K $891K $804K $1.60M $1.50M $1.43M
Total Non-Current Liabilities $251K $251K $237K $0 $0 $0 $0 $0
Total Liabilities $1.41M $1.65M $975K $891K $804K $1.60M $1.50M $1.43M
Total Debt (incl. Leases) $266K $279K $294K $308K $294K $30K $48K $65K
Common Stock $2.2K $1.8K $1.7K $1.6K $1.4K $1.1K $715 $325
Retained Earnings -$48.92M -$45.36M -$44.05M -$40.65M -$37.88M -$31.65M -$25.94M -$20.00M
Accumulated Other Comp. Income -$3.6K -$5.2K -$3.2K -$2.8K -$2.1K -$2.0K -$2.2K -$9.8K
Total Stockholders' Equity $11.08M $12.53M $13.48M $15.20M $15.73M $19.24M $20.25M $13.95M
Total Equity $13.69M $12.52M $13.47M $15.20M $15.73M $19.24M $20.25M $13.95M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$20.64M -$8.71M -$9.21M -$2.00M
Depreciation & Amortization $1.12M $9.9K $25K $3.9K
Stock-Based Compensation $1.17M $249K $624K $234K
Change in Inventory -- -- -$19K --
Operating Cash Flow -$5.85M -$4.86M -$7.00M -$1.35M
Capital Expenditure -- -- -$3.5K -$43K
Free Cash Flow -- -- -$7.00M -$1.39M
Investing Cash Flow -- $65K -$3.5K -$43K
Common Stock Issued $4.63M $1.33M $6.20M $2.00M
Financing Cash Flow $7.27M $4.13M $7.06M $2.05M
Net Change in Cash $1.42M -$671K $56K $660K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$3.55M -$1.31M -$3.40M -$2.77M -$7.62M -$5.42M -$4.84M -$1.95M
Depreciation & Amortization $283K $280K $277K $283K $256 $252 $250 $255
Stock-Based Compensation $1.05M $12K $1.09M -$33K $1.10M $51K $51K $51K
Operating Cash Flow -$1.15M -$261K -$1.31M -$1.08M -$1.24M -$1.26M -$2.27M -$1.13M
Common Stock Issued -- -- -- $2.21M $1.32M $431K $655K $760K
Financing Cash Flow -- -- -- $2.08M $1.62M $1.28M $2.29M $1.12M
Net Change in Cash $427K $56K -$1.31M $1.01M $380K $24K $10K -$7.1K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 54.9% 61.7% 59.0% 54.3%
Operating Margin -3954.3% -1294.4% -1260.3% -22279.7%
Net Profit Margin -4526.8% -1413.6% -1259.4% -22352.1%
Return on Equity (ROE) -135.8% -62.4% -1189.1% -325.4%
Return on Assets (ROA) -128.3% -56.6% -876.7% -199.2%
Current Ratio 1.74x 0.05x 3.96x 2.67x
Quick Ratio 1.67x 0.04x 3.87x 2.62x
Debt to Equity 0.02x 0.00x 0.17x 0.30x
Revenue Growth (YoY) -26.0% -15.8% +8083.2% --
Gross Profit Growth (YoY) -34.1% -11.9% +8796.9% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 52.9% 54.4% 52.4% 54.9% 60.6% 61.0% 57.6% 61.7%
Operating Margin -2887.5% -4005.6% -4067.3% -4015.7% -4022.7% -2573.6% -1992.0% -1294.4%
Net Profit Margin -3673.7% -4791.3% -4632.8% -4526.8% -4245.3% -2752.3% -2187.1% -1413.6%
Return on Equity (ROE) -99.6% -120.6% -142.5% -135.8% -126.0% -73.8% -55.2% -62.4%
Return on Assets (ROA) -73.1% -106.6% -132.9% -128.3% -119.9% -68.1% -51.4% -56.6%
Current Ratio 1.28x 0.18x 0.29x 1.74x 0.74x 0.07x 0.12x 0.05x
Quick Ratio 0.57x 0.16x 0.24x 1.67x 0.60x 0.06x 0.05x 0.04x
Debt to Equity 0.02x 0.02x 0.02x 0.02x 0.02x 0.00x 0.00x 0.00x
Revenue Growth (YoY) -17.5% -59.1% -37.9% -10.3% -36.8% +3.0% -48.9% -56.9%
Gross Profit Growth (YoY) -24.6% -50.8% -53.3% -40.7% -38.4% +28.9% -57.9% -43.8%
Source: SEC EDGAR CompanyFacts (CIK 0001938046) · from March 31, 2022 Data through September 30, 2026 · synced Nov 21, 2026, 05:10 UTC · Open in terminal